nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—ADORA2A—NGF-independant TRKA activation—NTRK2—glaucoma	0.0269	0.148	CbGpPWpGaD
Regadenoson—ADORA2A—Activation of TRKA receptors—NTRK2—glaucoma	0.0233	0.128	CbGpPWpGaD
Regadenoson—ADORA2A—NGF-independant TRKA activation—NTRK1—glaucoma	0.022	0.121	CbGpPWpGaD
Regadenoson—ADORA2A—Activation of TRKA receptors—NTRK1—glaucoma	0.019	0.105	CbGpPWpGaD
Regadenoson—ADORA2A—Activation of TRKA receptors—NGF—glaucoma	0.0154	0.0849	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—ATOH7—glaucoma	0.00848	0.0467	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—SLC6A1—glaucoma	0.00784	0.0432	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—PTGFR—glaucoma	0.00573	0.0316	CbGpPWpGaD
Regadenoson—Adenosine triphosphate—ABCA1—glaucoma	0.00354	1	CrCbGaD
Regadenoson—ADORA2A—Circadian rythm related genes—OPN4—glaucoma	0.00338	0.0186	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00302	0.0167	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Other—SMO—glaucoma	0.00289	0.0159	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00277	0.0152	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00249	0.0137	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00237	0.0131	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00213	0.0118	CbGpPWpGaD
Regadenoson—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—glaucoma	0.00184	0.0101	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—OPN4—glaucoma	0.0018	0.00994	CbGpPWpGaD
Regadenoson—ADORA2A—Monoamine Transport—TNF—glaucoma	0.00165	0.00911	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—PTGFR—glaucoma	0.00162	0.00895	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK2—glaucoma	0.00138	0.00757	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—NGFR—glaucoma	0.0012	0.00663	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—NTRK1—glaucoma	0.00114	0.0063	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK1—glaucoma	0.00112	0.00617	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—NTRK2—glaucoma	0.00106	0.00583	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—OPN4—glaucoma	0.00102	0.00562	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—OPN4—glaucoma	0.000926	0.0051	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PTGFR—glaucoma	0.000918	0.00506	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—glaucoma	0.000911	0.00502	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—NGFR—glaucoma	0.000908	0.005	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—FAS—glaucoma	0.000896	0.00493	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—NTRK1—glaucoma	0.000862	0.00475	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PTGFR—glaucoma	0.000834	0.00459	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—SMO—glaucoma	0.000819	0.00451	CbGpPWpGaD
Regadenoson—Mental disorder—Clonidine—glaucoma	0.000793	0.000973	CcSEcCtD
Regadenoson—Hypotension—Travoprost—glaucoma	0.000793	0.000973	CcSEcCtD
Regadenoson—Shock—Pilocarpine—glaucoma	0.000792	0.000972	CcSEcCtD
Regadenoson—Bronchospasm—Timolol—glaucoma	0.000791	0.000971	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—LRP12—glaucoma	0.000789	0.00435	CbGpPWpGaD
Regadenoson—Erythema—Clonidine—glaucoma	0.000788	0.000967	CcSEcCtD
Regadenoson—Tachycardia—Pilocarpine—glaucoma	0.000786	0.000964	CcSEcCtD
Regadenoson—Hypoaesthesia—Betaxolol—glaucoma	0.000784	0.000962	CcSEcCtD
Regadenoson—Angina pectoris—Timolol—glaucoma	0.000783	0.000961	CcSEcCtD
Regadenoson—Hypotension—Brinzolamide—glaucoma	0.000783	0.000961	CcSEcCtD
Regadenoson—Hyperhidrosis—Pilocarpine—glaucoma	0.000778	0.000955	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000776	0.000953	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Travoprost—glaucoma	0.000773	0.000949	CcSEcCtD
Regadenoson—Insomnia—Dorzolamide—glaucoma	0.000771	0.000946	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Brimonidine—glaucoma	0.00077	0.000945	CcSEcCtD
Regadenoson—Feeling abnormal—Acetazolamide—glaucoma	0.000766	0.00094	CcSEcCtD
Regadenoson—Hypersensitivity—Apraclonidine—glaucoma	0.000766	0.00094	CcSEcCtD
Regadenoson—Paraesthesia—Dorzolamide—glaucoma	0.000765	0.000939	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000763	0.000937	CcSEcCtD
Regadenoson—Pain—Brimonidine—glaucoma	0.000763	0.000936	CcSEcCtD
Regadenoson—Dyspnoea—Dorzolamide—glaucoma	0.00076	0.000932	CcSEcCtD
Regadenoson—Insomnia—Brinzolamide—glaucoma	0.000758	0.00093	CcSEcCtD
Regadenoson—Somnolence—Dorzolamide—glaucoma	0.000758	0.00093	CcSEcCtD
Regadenoson—Dyspnoea—Travoprost—glaucoma	0.000756	0.000928	CcSEcCtD
Regadenoson—Hypotension—Pilocarpine—glaucoma	0.000752	0.000923	CcSEcCtD
Regadenoson—Paraesthesia—Brinzolamide—glaucoma	0.000752	0.000923	CcSEcCtD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000751	0.00414	CbGpPWpGaD
Regadenoson—Dyspnoea—Brinzolamide—glaucoma	0.000747	0.000917	CcSEcCtD
Regadenoson—Asthenia—Apraclonidine—glaucoma	0.000746	0.000915	CcSEcCtD
Regadenoson—Somnolence—Brinzolamide—glaucoma	0.000745	0.000914	CcSEcCtD
Regadenoson—Vision blurred—Clonidine—glaucoma	0.000743	0.000911	CcSEcCtD
Regadenoson—Urticaria—Acetazolamide—glaucoma	0.000739	0.000906	CcSEcCtD
Regadenoson—Tremor—Clonidine—glaucoma	0.000738	0.000906	CcSEcCtD
Regadenoson—Eye disorder—Betaxolol—glaucoma	0.000736	0.000904	CcSEcCtD
Regadenoson—Tinnitus—Betaxolol—glaucoma	0.000735	0.000902	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000734	0.0009	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Travoprost—glaucoma	0.000732	0.000899	CcSEcCtD
Regadenoson—Cardiac disorder—Betaxolol—glaucoma	0.000731	0.000897	CcSEcCtD
Regadenoson—Flushing—Betaxolol—glaucoma	0.000731	0.000897	CcSEcCtD
Regadenoson—Ill-defined disorder—Clonidine—glaucoma	0.000731	0.000897	CcSEcCtD
Regadenoson—Pain—Dorzolamide—glaucoma	0.000729	0.000894	CcSEcCtD
Regadenoson—Insomnia—Pilocarpine—glaucoma	0.000728	0.000894	CcSEcCtD
Regadenoson—Pain—Travoprost—glaucoma	0.000726	0.00089	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000723	0.000888	CcSEcCtD
Regadenoson—Paraesthesia—Pilocarpine—glaucoma	0.000723	0.000887	CcSEcCtD
Regadenoson—Asthenia—Bimatoprost—glaucoma	0.000723	0.000887	CcSEcCtD
Regadenoson—Angioedema—Clonidine—glaucoma	0.00072	0.000883	CcSEcCtD
Regadenoson—Dyspnoea—Pilocarpine—glaucoma	0.000718	0.000881	CcSEcCtD
Regadenoson—Pain—Brinzolamide—glaucoma	0.000716	0.000879	CcSEcCtD
Regadenoson—Somnolence—Pilocarpine—glaucoma	0.000716	0.000878	CcSEcCtD
Regadenoson—Angiopathy—Betaxolol—glaucoma	0.000715	0.000877	CcSEcCtD
Regadenoson—Immune system disorder—Betaxolol—glaucoma	0.000712	0.000873	CcSEcCtD
Regadenoson—Diarrhoea—Apraclonidine—glaucoma	0.000711	0.000873	CcSEcCtD
Regadenoson—Malaise—Clonidine—glaucoma	0.00071	0.000872	CcSEcCtD
Regadenoson—Mediastinal disorder—Betaxolol—glaucoma	0.00071	0.000871	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000709	0.00391	CbGpPWpGaD
Regadenoson—Syncope—Clonidine—glaucoma	0.000707	0.000867	CcSEcCtD
Regadenoson—Feeling abnormal—Dorzolamide—glaucoma	0.000702	0.000862	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—NGF—glaucoma	0.000701	0.00386	CbGpPWpGaD
Regadenoson—Feeling abnormal—Travoprost—glaucoma	0.000699	0.000858	CcSEcCtD
Regadenoson—Gastrointestinal pain—Dorzolamide—glaucoma	0.000697	0.000855	CcSEcCtD
Regadenoson—Palpitations—Clonidine—glaucoma	0.000696	0.000854	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000695	0.000853	CcSEcCtD
Regadenoson—Gastrointestinal pain—Travoprost—glaucoma	0.000694	0.000851	CcSEcCtD
Regadenoson—Loss of consciousness—Clonidine—glaucoma	0.000692	0.00085	CcSEcCtD
Regadenoson—Feeling abnormal—Brinzolamide—glaucoma	0.00069	0.000847	CcSEcCtD
Regadenoson—Mental disorder—Betaxolol—glaucoma	0.00069	0.000847	CcSEcCtD
Regadenoson—Pain—Pilocarpine—glaucoma	0.000689	0.000845	CcSEcCtD
Regadenoson—Cough—Clonidine—glaucoma	0.000687	0.000844	CcSEcCtD
Regadenoson—Dizziness—Apraclonidine—glaucoma	0.000687	0.000843	CcSEcCtD
Regadenoson—Erythema—Betaxolol—glaucoma	0.000686	0.000842	CcSEcCtD
Regadenoson—Urticaria—Dorzolamide—glaucoma	0.000677	0.000831	CcSEcCtD
Regadenoson—Abdominal pain—Dorzolamide—glaucoma	0.000674	0.000827	CcSEcCtD
Regadenoson—Dysgeusia—Betaxolol—glaucoma	0.000672	0.000824	CcSEcCtD
Regadenoson—Arthralgia—Clonidine—glaucoma	0.000671	0.000823	CcSEcCtD
Regadenoson—Chest pain—Clonidine—glaucoma	0.000671	0.000823	CcSEcCtD
Regadenoson—Abdominal pain—Travoprost—glaucoma	0.000671	0.000823	CcSEcCtD
Regadenoson—Anxiety—Clonidine—glaucoma	0.000668	0.00082	CcSEcCtD
Regadenoson—Asthenia—Acetazolamide—glaucoma	0.000667	0.000819	CcSEcCtD
Regadenoson—Dizziness—Bimatoprost—glaucoma	0.000666	0.000818	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000666	0.000817	CcSEcCtD
Regadenoson—Urticaria—Brinzolamide—glaucoma	0.000666	0.000817	CcSEcCtD
Regadenoson—Feeling abnormal—Pilocarpine—glaucoma	0.000664	0.000814	CcSEcCtD
Regadenoson—Discomfort—Clonidine—glaucoma	0.000663	0.000813	CcSEcCtD
Regadenoson—Vomiting—Apraclonidine—glaucoma	0.000661	0.000811	CcSEcCtD
Regadenoson—Gastrointestinal pain—Pilocarpine—glaucoma	0.000658	0.000808	CcSEcCtD
Regadenoson—Hypersensitivity—Brimonidine—glaucoma	0.000657	0.000807	CcSEcCtD
Regadenoson—Bradycardia—Timolol—glaucoma	0.000655	0.000804	CcSEcCtD
Regadenoson—Dermatitis—Apraclonidine—glaucoma	0.000655	0.000803	CcSEcCtD
Regadenoson—Headache—Apraclonidine—glaucoma	0.000651	0.000799	CcSEcCtD
Regadenoson—Vision blurred—Betaxolol—glaucoma	0.000646	0.000793	CcSEcCtD
Regadenoson—Tremor—Betaxolol—glaucoma	0.000643	0.000789	CcSEcCtD
Regadenoson—Asthenia—Brimonidine—glaucoma	0.00064	0.000786	CcSEcCtD
Regadenoson—Abdominal pain—Pilocarpine—glaucoma	0.000637	0.000781	CcSEcCtD
Regadenoson—Ill-defined disorder—Betaxolol—glaucoma	0.000636	0.000781	CcSEcCtD
Regadenoson—Diarrhoea—Acetazolamide—glaucoma	0.000636	0.000781	CcSEcCtD
Regadenoson—Rash—Bimatoprost—glaucoma	0.000635	0.00078	CcSEcCtD
Regadenoson—Dermatitis—Bimatoprost—glaucoma	0.000635	0.000779	CcSEcCtD
Regadenoson—Shock—Clonidine—glaucoma	0.000633	0.000776	CcSEcCtD
Regadenoson—Connective tissue disorder—Timolol—glaucoma	0.000633	0.000776	CcSEcCtD
Regadenoson—Headache—Bimatoprost—glaucoma	0.000631	0.000775	CcSEcCtD
Regadenoson—Nervous system disorder—Clonidine—glaucoma	0.000631	0.000774	CcSEcCtD
Regadenoson—Hypersensitivity—Dorzolamide—glaucoma	0.000628	0.00077	CcSEcCtD
Regadenoson—Tachycardia—Clonidine—glaucoma	0.000628	0.00077	CcSEcCtD
Regadenoson—Hypersensitivity—Travoprost—glaucoma	0.000625	0.000767	CcSEcCtD
Regadenoson—Skin disorder—Clonidine—glaucoma	0.000625	0.000766	CcSEcCtD
Regadenoson—Hyperhidrosis—Clonidine—glaucoma	0.000622	0.000763	CcSEcCtD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00062	0.00341	CbGpPWpGaD
Regadenoson—Malaise—Betaxolol—glaucoma	0.000619	0.000759	CcSEcCtD
Regadenoson—Nausea—Apraclonidine—glaucoma	0.000617	0.000758	CcSEcCtD
Regadenoson—Hypersensitivity—Brinzolamide—glaucoma	0.000617	0.000757	CcSEcCtD
Regadenoson—Syncope—Betaxolol—glaucoma	0.000615	0.000755	CcSEcCtD
Regadenoson—Dizziness—Acetazolamide—glaucoma	0.000615	0.000754	CcSEcCtD
Regadenoson—Asthenia—Dorzolamide—glaucoma	0.000611	0.00075	CcSEcCtD
Regadenoson—Asthenia—Travoprost—glaucoma	0.000609	0.000747	CcSEcCtD
Regadenoson—Palpitations—Betaxolol—glaucoma	0.000606	0.000744	CcSEcCtD
Regadenoson—Loss of consciousness—Betaxolol—glaucoma	0.000603	0.00074	CcSEcCtD
Regadenoson—Eye disorder—Timolol—glaucoma	0.000602	0.000738	CcSEcCtD
Regadenoson—Asthenia—Brinzolamide—glaucoma	0.000601	0.000738	CcSEcCtD
Regadenoson—Hypotension—Clonidine—glaucoma	0.000601	0.000737	CcSEcCtD
Regadenoson—Tinnitus—Timolol—glaucoma	0.0006	0.000736	CcSEcCtD
Regadenoson—Cough—Betaxolol—glaucoma	0.000599	0.000735	CcSEcCtD
Regadenoson—Nausea—Bimatoprost—glaucoma	0.000599	0.000734	CcSEcCtD
Regadenoson—Cardiac disorder—Timolol—glaucoma	0.000597	0.000733	CcSEcCtD
Regadenoson—Hypersensitivity—Pilocarpine—glaucoma	0.000593	0.000728	CcSEcCtD
Regadenoson—Vomiting—Acetazolamide—glaucoma	0.000591	0.000725	CcSEcCtD
Regadenoson—Dizziness—Brimonidine—glaucoma	0.00059	0.000724	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Clonidine—glaucoma	0.000586	0.000719	CcSEcCtD
Regadenoson—Angiopathy—Timolol—glaucoma	0.000584	0.000717	CcSEcCtD
Regadenoson—Myalgia—Betaxolol—glaucoma	0.000584	0.000717	CcSEcCtD
Regadenoson—Arthralgia—Betaxolol—glaucoma	0.000584	0.000717	CcSEcCtD
Regadenoson—Chest pain—Betaxolol—glaucoma	0.000584	0.000717	CcSEcCtD
Regadenoson—Diarrhoea—Dorzolamide—glaucoma	0.000583	0.000715	CcSEcCtD
Regadenoson—Headache—Acetazolamide—glaucoma	0.000582	0.000715	CcSEcCtD
Regadenoson—Anxiety—Betaxolol—glaucoma	0.000582	0.000714	CcSEcCtD
Regadenoson—Insomnia—Clonidine—glaucoma	0.000582	0.000714	CcSEcCtD
Regadenoson—Immune system disorder—Timolol—glaucoma	0.000581	0.000713	CcSEcCtD
Regadenoson—Diarrhoea—Travoprost—glaucoma	0.000581	0.000712	CcSEcCtD
Regadenoson—Mediastinal disorder—Timolol—glaucoma	0.00058	0.000712	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00058	0.000712	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—BAD—glaucoma	0.000578	0.00318	CbGpPWpGaD
Regadenoson—Asthenia—Pilocarpine—glaucoma	0.000578	0.000709	CcSEcCtD
Regadenoson—Paraesthesia—Clonidine—glaucoma	0.000577	0.000709	CcSEcCtD
Regadenoson—Discomfort—Betaxolol—glaucoma	0.000577	0.000708	CcSEcCtD
Regadenoson—Dyspnoea—Clonidine—glaucoma	0.000573	0.000703	CcSEcCtD
Regadenoson—Diarrhoea—Brinzolamide—glaucoma	0.000573	0.000703	CcSEcCtD
Regadenoson—Somnolence—Clonidine—glaucoma	0.000572	0.000701	CcSEcCtD
Regadenoson—Mental disorder—Timolol—glaucoma	0.000564	0.000692	CcSEcCtD
Regadenoson—Dizziness—Dorzolamide—glaucoma	0.000563	0.000691	CcSEcCtD
Regadenoson—Rash—Brimonidine—glaucoma	0.000563	0.00069	CcSEcCtD
Regadenoson—Dermatitis—Brimonidine—glaucoma	0.000562	0.00069	CcSEcCtD
Regadenoson—Dizziness—Travoprost—glaucoma	0.000561	0.000688	CcSEcCtD
Regadenoson—Erythema—Timolol—glaucoma	0.00056	0.000688	CcSEcCtD
Regadenoson—Headache—Brimonidine—glaucoma	0.000559	0.000686	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Clonidine—glaucoma	0.000555	0.000681	CcSEcCtD
Regadenoson—Dizziness—Brinzolamide—glaucoma	0.000554	0.00068	CcSEcCtD
Regadenoson—Nausea—Acetazolamide—glaucoma	0.000552	0.000678	CcSEcCtD
Regadenoson—Diarrhoea—Pilocarpine—glaucoma	0.000551	0.000676	CcSEcCtD
Regadenoson—Shock—Betaxolol—glaucoma	0.000551	0.000676	CcSEcCtD
Regadenoson—Pain—Clonidine—glaucoma	0.00055	0.000675	CcSEcCtD
Regadenoson—Nervous system disorder—Betaxolol—glaucoma	0.000549	0.000674	CcSEcCtD
Regadenoson—Dysgeusia—Timolol—glaucoma	0.000549	0.000673	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—OPN4—glaucoma	0.000547	0.00301	CbGpPWpGaD
Regadenoson—Tachycardia—Betaxolol—glaucoma	0.000546	0.00067	CcSEcCtD
Regadenoson—Skin disorder—Betaxolol—glaucoma	0.000544	0.000667	CcSEcCtD
Regadenoson—Vomiting—Dorzolamide—glaucoma	0.000542	0.000665	CcSEcCtD
Regadenoson—Hyperhidrosis—Betaxolol—glaucoma	0.000541	0.000664	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—EDN1—glaucoma	0.00054	0.00298	CbGpPWpGaD
Regadenoson—Rash—Dorzolamide—glaucoma	0.000537	0.000659	CcSEcCtD
Regadenoson—Dermatitis—Dorzolamide—glaucoma	0.000537	0.000659	CcSEcCtD
Regadenoson—Rash—Travoprost—glaucoma	0.000535	0.000656	CcSEcCtD
Regadenoson—Dermatitis—Travoprost—glaucoma	0.000534	0.000656	CcSEcCtD
Regadenoson—Headache—Dorzolamide—glaucoma	0.000534	0.000655	CcSEcCtD
Regadenoson—Vomiting—Brinzolamide—glaucoma	0.000533	0.000654	CcSEcCtD
Regadenoson—Dizziness—Pilocarpine—glaucoma	0.000532	0.000653	CcSEcCtD
Regadenoson—Headache—Travoprost—glaucoma	0.000532	0.000652	CcSEcCtD
Regadenoson—Nausea—Brimonidine—glaucoma	0.00053	0.00065	CcSEcCtD
Regadenoson—Feeling abnormal—Clonidine—glaucoma	0.00053	0.00065	CcSEcCtD
Regadenoson—Rash—Brinzolamide—glaucoma	0.000528	0.000648	CcSEcCtD
Regadenoson—Vision blurred—Timolol—glaucoma	0.000528	0.000648	CcSEcCtD
Regadenoson—Dermatitis—Brinzolamide—glaucoma	0.000528	0.000648	CcSEcCtD
Regadenoson—Gastrointestinal pain—Clonidine—glaucoma	0.000526	0.000645	CcSEcCtD
Regadenoson—Headache—Brinzolamide—glaucoma	0.000525	0.000644	CcSEcCtD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000523	0.00288	CbGpPWpGaD
Regadenoson—Hypotension—Betaxolol—glaucoma	0.000523	0.000642	CcSEcCtD
Regadenoson—Angioedema—Timolol—glaucoma	0.000512	0.000628	CcSEcCtD
Regadenoson—Vomiting—Pilocarpine—glaucoma	0.000512	0.000628	CcSEcCtD
Regadenoson—Urticaria—Clonidine—glaucoma	0.000511	0.000627	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00051	0.000626	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—HEYL—glaucoma	0.000509	0.0028	CbGpPWpGaD
Regadenoson—Abdominal pain—Clonidine—glaucoma	0.000508	0.000624	CcSEcCtD
Regadenoson—Rash—Pilocarpine—glaucoma	0.000508	0.000623	CcSEcCtD
Regadenoson—Dermatitis—Pilocarpine—glaucoma	0.000507	0.000622	CcSEcCtD
Regadenoson—Insomnia—Betaxolol—glaucoma	0.000506	0.000621	CcSEcCtD
Regadenoson—Nausea—Dorzolamide—glaucoma	0.000506	0.000621	CcSEcCtD
Regadenoson—Headache—Pilocarpine—glaucoma	0.000504	0.000619	CcSEcCtD
Regadenoson—Nausea—Travoprost—glaucoma	0.000504	0.000618	CcSEcCtD
Regadenoson—Paraesthesia—Betaxolol—glaucoma	0.000503	0.000617	CcSEcCtD
Regadenoson—Syncope—Timolol—glaucoma	0.000503	0.000617	CcSEcCtD
Regadenoson—Dyspnoea—Betaxolol—glaucoma	0.000499	0.000612	CcSEcCtD
Regadenoson—Nausea—Brinzolamide—glaucoma	0.000498	0.000611	CcSEcCtD
Regadenoson—Palpitations—Timolol—glaucoma	0.000495	0.000608	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—PTGFR—glaucoma	0.000493	0.00271	CbGpPWpGaD
Regadenoson—Loss of consciousness—Timolol—glaucoma	0.000492	0.000604	CcSEcCtD
Regadenoson—Cough—Timolol—glaucoma	0.000489	0.0006	CcSEcCtD
Regadenoson—Hypertension—Timolol—glaucoma	0.000484	0.000594	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Betaxolol—glaucoma	0.000483	0.000593	CcSEcCtD
Regadenoson—Pain—Betaxolol—glaucoma	0.000479	0.000587	CcSEcCtD
Regadenoson—Nausea—Pilocarpine—glaucoma	0.000478	0.000587	CcSEcCtD
Regadenoson—Myalgia—Timolol—glaucoma	0.000477	0.000585	CcSEcCtD
Regadenoson—Arthralgia—Timolol—glaucoma	0.000477	0.000585	CcSEcCtD
Regadenoson—Chest pain—Timolol—glaucoma	0.000477	0.000585	CcSEcCtD
Regadenoson—Anxiety—Timolol—glaucoma	0.000475	0.000583	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000474	0.000581	CcSEcCtD
Regadenoson—Hypersensitivity—Clonidine—glaucoma	0.000474	0.000581	CcSEcCtD
Regadenoson—ADORA2A—GPCR ligand binding—C3—glaucoma	0.000472	0.0026	CbGpPWpGaD
Regadenoson—Discomfort—Timolol—glaucoma	0.000471	0.000578	CcSEcCtD
Regadenoson—Asthenia—Clonidine—glaucoma	0.000461	0.000566	CcSEcCtD
Regadenoson—Feeling abnormal—Betaxolol—glaucoma	0.000461	0.000566	CcSEcCtD
Regadenoson—Anaphylactic shock—Timolol—glaucoma	0.000457	0.000561	CcSEcCtD
Regadenoson—Shock—Timolol—glaucoma	0.00045	0.000552	CcSEcCtD
Regadenoson—Nervous system disorder—Timolol—glaucoma	0.000448	0.00055	CcSEcCtD
Regadenoson—Urticaria—Betaxolol—glaucoma	0.000445	0.000546	CcSEcCtD
Regadenoson—Skin disorder—Timolol—glaucoma	0.000444	0.000545	CcSEcCtD
Regadenoson—Hyperhidrosis—Timolol—glaucoma	0.000442	0.000543	CcSEcCtD
Regadenoson—Diarrhoea—Clonidine—glaucoma	0.00044	0.00054	CcSEcCtD
Regadenoson—Hypotension—Timolol—glaucoma	0.000427	0.000524	CcSEcCtD
Regadenoson—Dizziness—Clonidine—glaucoma	0.000425	0.000522	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—SMO—glaucoma	0.00042	0.00232	CbGpPWpGaD
Regadenoson—Musculoskeletal discomfort—Timolol—glaucoma	0.000417	0.000511	CcSEcCtD
Regadenoson—Insomnia—Timolol—glaucoma	0.000414	0.000508	CcSEcCtD
Regadenoson—Hypersensitivity—Betaxolol—glaucoma	0.000412	0.000506	CcSEcCtD
Regadenoson—Paraesthesia—Timolol—glaucoma	0.000411	0.000504	CcSEcCtD
Regadenoson—Vomiting—Clonidine—glaucoma	0.000409	0.000502	CcSEcCtD
Regadenoson—Dyspnoea—Timolol—glaucoma	0.000408	0.0005	CcSEcCtD
Regadenoson—Somnolence—Timolol—glaucoma	0.000407	0.000499	CcSEcCtD
Regadenoson—Rash—Clonidine—glaucoma	0.000405	0.000498	CcSEcCtD
Regadenoson—Dermatitis—Clonidine—glaucoma	0.000405	0.000497	CcSEcCtD
Regadenoson—Headache—Clonidine—glaucoma	0.000403	0.000494	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—CDKN1B—glaucoma	0.000402	0.00222	CbGpPWpGaD
Regadenoson—Asthenia—Betaxolol—glaucoma	0.000402	0.000493	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Timolol—glaucoma	0.000395	0.000485	CcSEcCtD
Regadenoson—Pain—Timolol—glaucoma	0.000391	0.00048	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—RPTOR—glaucoma	0.000385	0.00212	CbGpPWpGaD
Regadenoson—Diarrhoea—Betaxolol—glaucoma	0.000383	0.00047	CcSEcCtD
Regadenoson—Nausea—Clonidine—glaucoma	0.000382	0.000469	CcSEcCtD
Regadenoson—Feeling abnormal—Timolol—glaucoma	0.000377	0.000462	CcSEcCtD
Regadenoson—Gastrointestinal pain—Timolol—glaucoma	0.000374	0.000459	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—NCK2—glaucoma	0.000373	0.00206	CbGpPWpGaD
Regadenoson—Dizziness—Betaxolol—glaucoma	0.00037	0.000454	CcSEcCtD
Regadenoson—Urticaria—Timolol—glaucoma	0.000363	0.000446	CcSEcCtD
Regadenoson—Abdominal pain—Timolol—glaucoma	0.000362	0.000444	CcSEcCtD
Regadenoson—Vomiting—Betaxolol—glaucoma	0.000356	0.000437	CcSEcCtD
Regadenoson—Rash—Betaxolol—glaucoma	0.000353	0.000433	CcSEcCtD
Regadenoson—Dermatitis—Betaxolol—glaucoma	0.000353	0.000433	CcSEcCtD
Regadenoson—Headache—Betaxolol—glaucoma	0.000351	0.00043	CcSEcCtD
Regadenoson—Hypersensitivity—Timolol—glaucoma	0.000337	0.000413	CcSEcCtD
Regadenoson—ADORA2A—Circadian rythm related genes—TP53—glaucoma	0.000335	0.00185	CbGpPWpGaD
Regadenoson—Nausea—Betaxolol—glaucoma	0.000333	0.000408	CcSEcCtD
Regadenoson—Asthenia—Timolol—glaucoma	0.000328	0.000403	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—HDAC9—glaucoma	0.000317	0.00175	CbGpPWpGaD
Regadenoson—Diarrhoea—Timolol—glaucoma	0.000313	0.000384	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—EDN1—glaucoma	0.000305	0.00168	CbGpPWpGaD
Regadenoson—Dizziness—Timolol—glaucoma	0.000302	0.000371	CcSEcCtD
Regadenoson—Vomiting—Timolol—glaucoma	0.000291	0.000357	CcSEcCtD
Regadenoson—Rash—Timolol—glaucoma	0.000288	0.000354	CcSEcCtD
Regadenoson—Dermatitis—Timolol—glaucoma	0.000288	0.000354	CcSEcCtD
Regadenoson—Headache—Timolol—glaucoma	0.000286	0.000352	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—EDN1—glaucoma	0.000277	0.00153	CbGpPWpGaD
Regadenoson—Nausea—Timolol—glaucoma	0.000272	0.000333	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—C3—glaucoma	0.000267	0.00147	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SMO—glaucoma	0.000248	0.00137	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—C3—glaucoma	0.000242	0.00133	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NTRK2—glaucoma	0.000227	0.00125	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NGFR—glaucoma	0.000195	0.00107	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NTRK1—glaucoma	0.000185	0.00102	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CDKN2B—glaucoma	0.000171	0.00094	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EDN1—glaucoma	0.000164	0.000902	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NGF—glaucoma	0.00015	0.000829	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—C3—glaucoma	0.000143	0.000788	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—APOE—glaucoma	0.000133	0.000734	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CAV1—glaucoma	0.000132	0.000727	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FN1—glaucoma	0.000126	0.000692	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—BAD—glaucoma	0.000124	0.000684	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOS3—glaucoma	9.98e-05	0.00055	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CDKN1B—glaucoma	8.64e-05	0.000476	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MMP9—glaucoma	8.01e-05	0.000441	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VEGFA—glaucoma	7.19e-05	0.000396	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TP53—glaucoma	5.43e-05	0.000299	CbGpPWpGaD
